Current Event 

Overview 
Register
Day 1
Day 2
Short Course 
Hotel & Travel
PDF Download
Sponsor/Exhibit
Posters 
Press Pass 
Request Brochure 

DFX mini Banner  

Web Podcasts 

 

 

 

 

 

 

 

 

 


Corporate Sponsor:
 


NuGen 


Lead Sponsoring Publications:
 


Bio-IT World 

GEN 

Nature 

Science AAAS 

The Scientist 


Sponsoring Publications:
 


Drug Discovery News 

Genome Technology 

Insight Pharma Reports 

PharmaVoice 


Media Partner:
 


 

 

 

 


Web Partners:
 


Biospace 

Genomeweb Logo 


Innovative Sample Prep and Target Enrichment in Clinical Diagnostics Conference - 2012

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Pre-analytical processing is a pivotal part of clinical diagnostics. Its modernization should closely follow or even precede the emergence of new diagnostic technologies. Target enrichment as part of pre-analytical processing has the ability to significantly increase sensitivity and specificity of a test that is run on a heterogeneous sample or a sample that contains a low concentration of analyte. This conference is designed to demonstrate the latest advances in pre-analytical processing, sample preparation and target enrichment for clinical laboratory testing.

TOPICS INCLUDE:


  • Pre-Analytical Challenges in Point-of-Care Testing
  • Sample Prep and Target Enrichment in Molecular Diagnostics for Infectious Diseases
  • Sample Prep and Target Enrichment in Molecular Diagnostics of Cancer
  • Pre-Analytical Issues in Mass Spectrometry Applications
  • Sample Prep for Next Generation Sequencing

Dinner Short Course* 

Tuesday, April 17 | 6:30 – 8:30 pm


Guidelines for Commercial Launch of Novel Diagnostics 

This short course is focused on development of molecular diagnostics as they make their way from identification of a medical need through to commercial launch. The course will emphasize identification of critical hurdles that when addressed early, can materially accelerate progress. Vital areas to be addressed include disease management, validation, reimbursement strategies including provider engagement, regulatory pathway decisions and education of the medical community. Examples and case studies of diagnostic companies will be shared to illustrate a real world roadmap including:

  • Disease Management
  • Assay Validation
  • Regulatory Pathways and Considerations
  • Reimbursement
  • Acceptance and Adoption

Instructors:
Bill Cook, Principal, WECA
Dwight Denham, MBA, Director, Clinical Research, Health Economics &. Reimbursement Affairs (CHRA), Beckman Coulter, Inc.


*Separate Registration Required


 


By Series:
By Region: